Discovery of Rivaroxaban (Factor Xa Inhibitor)


The discovery of novel anticoagulants, and the search for novel orally active agents in particular, has been a long and difficult journey.  However, the recent (2008) launches of Bayer’s Factor Xa inhibitor (Rivaroxaban, BAY 59-7939) and Boehringer Ingelheim’s Thrombin inhibitor (Dabigatran, Pradaxa/Pradax, BIBR 953) are the first fruits of those efforts and both have the potential to offer marked improvements over the current clinical standards of care.  Whilst the discovery of both of these compounds has already been extensively reported (e.g. see leading J.Med.Chem articles for Dabigatran and Rivaroxaban respectively) and are well known stories in the medicinal chemistry community, the latest edition of Nature Reviews|Drug Discovery carries a really nice case history, from Bayer scientists, outlining the discovery of Rivaroxaban.  The review provides an excellent, concise overview of the anticoagulant field; the history behind the search for novel oral agents; the validation of factor Xa as a target; the discovery of rivaroxaban (including a brief overview of the key SAR and the somewhat serendipitous discovery of the important non-basic, chloro-thiophene binding motif); the clinical development of rivaroxaban; and an update on the current state-of-play and outlook for the future in the area.  A really good read, particularly for those less familiar with the area or looking for a brief update on the more recent clinical studies.

Advertisements
This entry was posted in Enzyme Inhibitors, Launched Drugs and tagged , , , , , , , , , , , , . Bookmark the permalink.

One Response to Discovery of Rivaroxaban (Factor Xa Inhibitor)

  1. Pingback: Xarelto Claims Attorney In Ross Texas - Xarelto Claims Lawsuit Directory

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s